NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -
Read Original Story

Studies: Statins Don’t Lower Cancer Risk


4 Star

Studies: Statins Don’t Lower Cancer Risk

Our Review Summary

This article presented the findings from two studies indicating that statin medications used to manage cholesterol levels did not prevent development of breast, prostate, lung or colorectal cancer or death from these cancers. Overall, a balanced story.


Does the story adequately discuss the costs of the intervention?

Not Satisfactory

Did not mention cost of treatment

Does the story adequately quantify the benefits of the treatment/test/product/procedure?


Mentioned lack of

benefit from statins for this purpose; also provided some details of side effects of statins

Does the story seem to grasp the quality of the evidence?


Provided a walk through the various types of clinical evidence.

Does the story use independent sources and identify conflicts of interest?


In addition to

quoting study authors, a quote from an editorial in the journal in which one of the articles was published was provided.

Does the story compare the new approach with existing alternatives?

Not Satisfactory

Did not mention other options for

reducing cancer risks.

Does the story establish the availability of the treatment/test/product/procedure?


Mentioned that statins are widely used and considered safe. Mentioned that use as cancer

preventative would be an off-label use (i.e. drugs not approved for this purpose)

Does the story establish the true novelty of the approach?


Examined a new use for a

class of medications (statins).

Total Score: 8 of 10 Satisfactory


Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.